We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $208M
1-Year Est. Return 72.91%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
AUM
$124M
AUM Growth
+$6.53M
Cap. Flow
+$434K
Cap. Flow %
0.35%
Top 10 Hldgs %
37.58%
Holding
73
New
11
Increased
24
Reduced
25
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$3.36M
2
GLD icon
SPDR Gold Trust
GLD
+$3.03M
3
CSX icon
CSX Corp
CSX
+$1.82M
4
UNP icon
Union Pacific
UNP
+$1.29M
5
FAST icon
Fastenal
FAST
+$1.2M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$4.1M
2
BDX icon
Becton Dickinson
BDX
+$3.52M
3
PANW icon
Palo Alto Networks
PANW
+$1.98M
4
AVGO icon
Broadcom
AVGO
+$1.76M
5
SYK icon
Stryker
SYK
+$1.54M

Sector Composition

Rank Sector Weight
1 Industrials 13.45%
2 Healthcare 12.76%
3 Consumer Discretionary 12.39%
4 Technology 12.06%
5 Financials 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVY icon
26
iShares Select Dividend ETF
DVY
$23.8B
$1.84M 1.48%
18,462
-509
-3% -$50.2K
TDG icon
27
TransDigm Group
TDG
$70.7B
$1.7M 1.37%
3,511
-130
-4% -$60.8K
IJH icon
28
iShares Core S&P Mid-Cap ETF
IJH
$121B
$1.67M 1.35%
43,100
+1,105
+3% +$42.4K
RVTY icon
29
Revvity
RVTY
$12.6B
$1.55M 1.25%
16,072
-225
-1% -$21K
AMGN icon
30
Amgen
AMGN
$209B
$1.48M 1.19%
8,025
-746
-9% -$134K
HON icon
31
Honeywell
HON
$76.4B
$1.43M 1.15%
8,684
+85
+1% +$13.5K
IUSV icon
32
iShares Core S&P US Value ETF
IUSV
$27.3B
$1.37M 1.1%
24,118
-5,457
-18% -$304K
LII icon
33
Lennox International
LII
$15B
$1.34M 1.08%
4,860
-150
-3% -$40.9K
CWB icon
34
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.41B
$1.33M 1.07%
25,110
+157
+0.6% +$8.22K
UNP icon
35
Union Pacific
UNP
$174B
$1.28M 1.03%
+7,545
New +$1.29M
V icon
36
Visa
V
$701B
$1.25M 1.01%
7,215
+210
+3% +$34.4K
WM icon
37
Waste Management
WM
$95B
$1.2M 0.97%
10,407
-250
-2% -$27.1K
FAST icon
38
Fastenal
FAST
$54.8B
$1.19M 0.96%
+72,960
New +$1.2M
APH icon
39
Amphenol
APH
$185B
$1.19M 0.96%
49,480
+6,300
+15% +$152K
CSCO icon
40
Cisco
CSCO
$443B
$1.15M 0.93%
21,039
+4,386
+26% +$242K
WDAY icon
41
Workday
WDAY
$41.5B
$1.12M 0.91%
+5,468
New +$1.1M
AMT icon
42
American Tower
AMT
$83.5B
$965K 0.78%
4,722
-155
-3% -$31.2K
SPY icon
43
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$941K 0.76%
3,212
CHDN icon
44
Churchill Downs
CHDN
$6.17B
$898K 0.73%
+15,600
New +$783K
LULU icon
45
lululemon athletica
LULU
$13.5B
$722K 0.58%
4,005
+2,185
+120% +$379K
TSCO icon
46
Tractor Supply
TSCO
$16.3B
$716K 0.58%
+32,925
New +$680K
CCI icon
47
Crown Castle
CCI
$34.6B
$705K 0.57%
5,408
-75
-1% -$9.64K
XOM icon
48
ExxonMobil
XOM
$650B
$705K 0.57%
7,718
-3,000
-28% -$232K
PAYX icon
49
Paychex
PAYX
$43.4B
$702K 0.57%
8,530
+150
+2% +$12.6K
DHR icon
50
Danaher
DHR
$138B
$664K 0.54%
5,240
-564
-10% -$66.8K

Similar funds

Geneva Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Geneva Partners held 73 positions worth $124M, up 5.6% from $117M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Geneva Partners's Q2 2019 filing shows 11 new, 24 increased, 25 reduced and 9 closed positions. Its largest new stake was Automatic Data Processing: 20,690 shares worth $3.42M. The largest sale was Xilinx Inc, an estimated $4.1M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Geneva Partners's largest Q2 2019 buy was Automatic Data Processing: 20,690 shares worth $3.42M.
  • Geneva Partners added most to CSX Corp in Q2 2019, an estimated $1.82M increase.
  • Geneva Partners's biggest Q2 2019 reduction was Stryker, cutting an estimated $1.54M.
  • Geneva Partners fully exited Xilinx Inc in Q2 2019, selling an estimated $4.1M.
  • Geneva Partners's ten largest holdings make up 38% of its $124M portfolio in Q2 2019.
  • Geneva Partners opened 11 new positions and closed 9 in Q2 2019.
  • Geneva Partners's portfolio value rose 5.6% quarter-over-quarter to $124M.

Based on Geneva Partners's 13F filing for Q2 2019, filed 31 Jul 2019.